-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
MBX2329
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/1438272-42-4.gif)
| Category | Influenza Virus |
| CAS | 1438272-42-4 |
| Description | MBX2329, a potent influenza virus inhibitor, specifically inhibits hemagglutinin (HA)-mediated viral entry with HIV/HA(H5) displaying IC90 of 8.6 μM. MBX2329 inhibits a wide spectrum of influenza A viruses, which includes the 2009 pandemic influenza virus A/H1N1/2009, highly pathogenic avian influenza (HPAI) virus A/H5N1, and oseltamivir-resistant A/H1N1 strains. |
Product Information
| Synonyms | MBX2329|1438272-42-4|CHEMBL4077590|SCHEMBL14969476|EX-A4615|HY-131069A|BS-52166|CS-0142262|E77158|1-[2-(2-ethylphenoxy)ethyl]azepane hydrochloride |
| Molecular Weight | 283.84 |
| Molecular Formula | C16H26ClNO |
| Canonical SMILES | CCC1=CC=CC=C1OCCN2CCCCCC2.Cl |
| Purity | 99.91% |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | White to off-white (Solid) |
| Storage | 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months -20°C, 1 month (sealed storage, away from moisture) |
| Complexity | 211 |
| Exact Mass | 283.1702921 |
| Target | Influenza Virus |